Glycemic Levels and Insulin Use Daily and During Hospital Shifts in Hospitalized Patients With Type 2 Diabetes
TIR improved continuously to nearly 90% in the CGM arm by discharge, compared to 60% in the POC arm, which plateaued after day 5, despite lower daily insulin doses in the CGM arm. These findings underscore the sustained effectiveness of CGM in enhancing glycemic levels throughout the entire duration of hospitalization.
Authors
- Kirsten Nørgaard (ORCID: https://orcid.org/0000-0003-1620-8271)
- Jonas Askø Andersen (ORCID: https://orcid.org/0000-0001-5213-5888)
- Simon Storgård Jensen (ORCID: https://orcid.org/0000-0002-3519-4103)
- Ulrik Pedersen‐Bjergaard (ORCID: https://orcid.org/0000-0003-0588-4880)
- Mikkel Thor Olsen (ORCID: https://orcid.org/0000-0003-2474-6168)
- Birgitte Lindegaard (ORCID: https://orcid.org/0000-0002-5236-8427)
- Louise Mathorne Rasmussen
- Carina Kirstine Klarskov (ORCID: https://orcid.org/0000-0001-7702-8595)
- Hans Gottlieb (ORCID: https://orcid.org/0000-0003-2945-8392)
- Suzanne Lunding
- Peter Lommer Kristensen
- Katrine Bagge Hansen
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Herlev Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1210/jendso/bvaf137
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Sanofi
- Jascha Fonden
- Dexcom
- Vissing Fonden
- Gentofte Hospital
- Novo Nordisk
- A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
- Torben og Alice Frimodts Fond
- Nordsjællands Hospital
- Novo Nordisk Fonden